Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PNMT | P11086 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367357 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| SCHEMBL29372643 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| SCHEMBL128713 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| SCHEMBL21538667 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| SCHEMBL335062 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| Iodide SCHEMBL25263727 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| Ammonia Solution, Strong SCHEMBL19549028 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| Iodide SCHEMBL21835042 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| Hydrochloric Acid SCHEMBL607840 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 | |
| Hydrochloric Acid SCHEMBL6251235 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1783 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595235-B2 | Process for producing 4,5-dihydro-1H-pyrazoles and intermediates | NOVO NORDISK A/S (DK) | 2026-04-07 | — | — | US | claimed |
| US-20260035372-A1 | METHOD FOR PREPARING (R)-KETOROLAC AND USE THEREOF | Yinuoke Medicine Science and Technology Co LTD (CN) | 2026-02-05 | — | — | US | claimed |
| US-20250346622-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-11-13 | — | — | US | claimed |
| EP-4624455-A1 | PREPARATION METHOD FOR CHIRAL PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF | Kangbaida (Sichuan) Biotechnology Co., Ltd. (CN) | 2025-10-01 | — | — | EP | claimed |
| US-20250276986-A1 | PREPARATION METHOD FOR CHIRAL PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF | Kangbaida (Sichuan) Biotechnology Co., Ltd (CN) | 2025-09-04 | — | — | US | claimed |
| EP-4090654-B1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | LUPIN LTD (IN) | 2025-07-09 | — | — | EP | claimed |
| US-12344592-B2 | Methods, processes and intermediates for preparing chroman compounds | LUPIN LIMITED (IN) | 2025-07-01 | — | — | US | claimed |
| CN-119275704-B | Continuous wave three-dimensional chiral perovskite laser and preparation method thereof | 浙江大学 | 2025-05-02 | — | — | CN | claimed |
| US-20250078176-A1 | ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS | BASF SE (DE) | 2025-03-06 | — | — | US | claimed |
| EP-4424717-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | Daiichi Sankyo Company, Limited (JP) | 2024-09-04 | — | — | EP | claimed |
| EP-0987332-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | Kaneka Corporation (JP) | 2000-03-22 | — | — | EP | claimed |
| EP-0857790-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | KANEKA CORPORATION (JP) | 1998-08-12 | — | — | EP | claimed |
| EP-0260668-B1 | SEPARATION OF DIASTEREOMERS | WARNER-LAMBERT COMPANY (US) | 1991-10-09 | — | — | EP | claimed |
| EP-0213785-B1 | METHOD FOR OPTICAL RESOLUTION OF DL-CYSTEINE AND (R,S)-1-(1-NAPHTHYL)ETHYLAMINE | NIPPON RIKAGAKUYAKUHIN CO., LTD. (JP) | 1990-02-07 | — | — | EP | claimed |
| US-4736060-A | Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl) ethylamine | NIPPON RIKAGAKUYAKUHIN CO., LTD. (JP) | 1988-04-05 | — | — | US | claimed |
| US-4681972-A | Separation of diastereomers | WARNER-LAMBERT COMPANY (US) | 1987-07-21 | — | — | US | claimed |
| EP-0213785-A1 | Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl)ethylamine | NIPPON RIKAGAKUYAKUHIN CO., LTD. (JP) | 1987-03-11 | — | — | EP | claimed |
| US-4335057-A | 4-(2',2,2'-Trihalogenoethyl)-cyclobutane-1-sulfonic acid salts with optically active bases | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | claimed |
| US-4299967-A | Process for producing optically active 2-(2,2-dihalogenovinyl)-cyclopropane-1-carboxylic acids substituted in the 3-position, and derivatives thereof, as well as novel 4-(2,2,2-trihalogenoethyl)-cyclobutane-1-sulfonic acid salts | CIBA-GEIGY CORPORATION (US) | 1981-11-10 | — | — | US | claimed |
| US-4129580-A | Resolution of certain asymmetric primary amines using lasalocid | HOFFMANN-LA ROCHE INC. (US) | 1978-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595235-B2 | Process for producing 4,5-dihydro-1H-pyrazoles and intermediates | PRMT1, SRM, CHRM1 | ALDH1A1 1603/4885CYP1A2 222/4885CYP2C9 496/4885 |
| US-20250346622-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | FUT6, FUT5, ST3GAL3 | ALDH1A1 450/4885CYP1A2 939/4885CYP2C9 1468/4885 |
| US-20250276986-A1 | PREPARATION METHOD FOR CHIRAL PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF | PIN1, DHPS, PPOX | ALDH1A1 763/4885CYP1A2 286/4885CYP2C9 232/4885 |
| US-12344592-B2 | Methods, processes and intermediates for preparing chroman compounds | CASR, CALCR, RYR1 | ALDH1A1 2602/4885CYP1A2 1366/4885CYP2C9 882/4885 |
| US-20260035372-A1 | METHOD FOR PREPARING (R)-KETOROLAC AND USE THEREOF | SRR, AGL, NOTUM | ALDH1A1 683/4885CYP1A2 206/4885CYP2C9 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.